Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avara has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a global pharmaceutical company, as part of a continuing expansion of its global footprint.
read more
Avara Pharmaceutical Services has signed an agreement with Pfizer to acquire the Liscate, Italy sterile manufacturing facility.
read more
Avara has signed and closed on an agreement with AstraZeneca to acquire the Reims, France manufacturing and distribution facility.
read more
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced a multi-year investment in its global hydration capabilities. The ...
read more
Avantor Inc, a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it has completed its previously announced acquisition of Ritter...
read more
Avantor, Inc. announced it will create a new manufacturing and distribution hub in Singapore by integrating its existing distribution facility with new manufacturing operations.
read more
Monday, November 01, 2021
Avantor announced that it has opened a new single-use facility in Hillegom, Netherlands in early October 2021. The site is Avantor's second single-use location in Europe after its Tilburg, Netherlands site and is a significant addition to the Company...
read more
Friday, February 11, 2022
Avantor, Inc. has started construction on a distribution center which will help expedite access to essential production materials for biopharmaceutical manufacturers in Ireland. Expected to open later this year, the facility will significantly ...
read more
Tuesday, January 10, 2023
Avantor, Inc. has entered into a multi-year supply and services agreement with Catalent, Inc. enabling the development and supply of better treatments for patients worldwide.
read more
Avantor Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of...
read more
Wednesday, February 10, 2021
Avacta and Mologic have entered into a commercial partnership to accelerate to market Avacta’s AffiDX SARS-CoV-2 lateral flow rapid antigen test.
read more
Avacta has announce the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva and show positive initial performance data.
read more
Wednesday, September 02, 2020
Avacta Group has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.
read more
Wednesday, August 12, 2020
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
read more
Avacta Group plc, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, announced that it has received notice of registration of its AffiDX® SARS-CoV-2 antigen lateral flow test in ...
read more